Casi Pharmaceuticals (CASI)

[Rocky I]

CASI Pharmaceuticals To Present At The BIO International Convention
 
ROCKVILLE, Md., May 29, 2018 - CASI Pharmaceuticals, Inc. (CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the world, announces it will present at the BIO International Convention, June 4-7, 2018 in Boston, MA.

Presentation details are below:

Event: BIO International Convention 
Date: Monday, June 4, 2018 
Time: 3:30 P.M.
Presenter: James E. Goldschmidt Ph.D., Senior Vice President, Business Development
Presentation Room: Theater 4

A copy of the presentation materials will be made available directly through the Investor Relations section of the company’s website, www.casipharmaceuticals.com, following the presentation.

COMPANY CONTACT:

CASI Pharmaceuticals, Inc.

240.864.2643

[e-mail]

INVESTOR CONTACT:

Solebury Trout

Jennifer Porcelli

646.378.2962

[e-mail]



Brennan Doyle

617.221.9005

[e-mail]

MEDIA CONTACT:

PressComm PR, LLC

Jamie Lacey-Moreira

410.299.3310

jamielace